Item 8.01 Other Events. On April 16, 2020, Gen
Post# of 36537
On April 16, 2020, Generex Biotechnology Corporation (“Generex”) received a letter of support from Montefiore Medical Center / Albert Einstein College of Medicine regarding Generex’s efforts to develop Generex’s li-Key-SARS-CoV-2 peptide vaccine with the goal to begin mass vaccination in the Fall of 2020. A copy of the letter of support is attached to this report as Exhibit 99.1 and is incorporated by reference herein.
Albert Einstein College of Medicine
Montefiore Health System is the University Hospital for Albert Einstein College of Medicine, serving the 3.1 million people living in the New York City region and the Hudson Valley. Albert Einstein College of Medicine is a premier, research-intensive medical school dedicated to leading biomedical investigation and the development of ethical and compassionate physicians and scientists. In 1955, Einstein was founded as the only medical institution upon which Albert Einstein bestowed the honor of his name, welcoming students of all creeds and races. Since then, Einstein has conferred 8,749 MD and 1,606 PhD degrees. Einstein strengthened its ability to thrive as a premier academic institution in 2015 by joining Montefiore Medicine. Building upon their decades-old cornerstone of partnership, Einstein and Montefiore are furthering the shared core missions of research excellence, outstanding medical education and improved human health.